The Lancet Oncology
| 1. | [News] Medical debt of people with cancer in the USA | Talha Burki | |
| 2. | [Articles] Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis | Huseyin Naci, Yichen Zhang, Steven Woloshin, Xiaodong Guan, Ziyue Xu, Anita K Wagner | |
| 3. | [Articles] Effect of Project Orbis participation by the Swiss regulator on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis | Matea Zosso-Pavic, Qiyu Li, Eiman Atiek, Anita Wolfer, Ulrich-Peter Rohr | |
| 4. | [Comment] Global cooperation and early access—clinical outcomes matter | Ariadna Tibau, Aaron S Kesselheim | |
| 5. | [News] ESTRO 2024 | David Collingridge | |
| 6. | [Articles] Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial | Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, Neal D Shore, Joost L Boormans, Ahmet Adil Esen, Thierry Lebret, Shuya Kandori, Dean F Bajorin, Laurence E M Krieger, Scot A Niglio, Edward M Uchio, Ho Kyung Seo, Ronald de Wit, Eric A Singer, Petros Grivas, Hiroyuki Nishiyama, Haojie Li, Pranshu Baranwal, Margot Van den Sigtenhorst-Fijlstra, Ekta Kapadia, Girish S Kulkarni | |
| 7. | [News] Protests in South Africa over unused cancer-treatment fund | Paul Adepoju | |
| 8. | [News] Cancer on the agenda during IAEA Director General's visit to Chile | Manjulika Das | |
| 9. | [Articles] Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study | Bob T Li, Funda Meric-Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian Anderson, Giuseppe Curigliano, Maria de Miguel, Maitri Kalra, Do-Youn Oh, Joon Oh Park, Sophie Postel-Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, Flavia Michelini, Ann Smith, Karime Kalil Machado, Cristina Saura, DESTINY-PanTumor01 study group | |
| 10. | [News] Inadequate government funding for UK hospices affects palliative care | Elizabeth Gourd | |
| 11. | [News] Biden administration delays long-awaited ban on menthol cigarettes | Bryant Furlow | |
| 12. | [Articles] Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study | Milena Sant, Claudia Vener, Roberto Lillini, Silvia Rossi, Simone Bonfarnuzzo, Rafael Marcos-Gragera, Marc Maynadié, Kaire Innos, Keiu Paapsi, Otto Visser, Alice Bernasconi, Elena Demuru, Corrado Di Benedetto, Seyed Mohsen Mousavi, Marcel Blum, Philip Went, Diego Serraino, Damien Bennett, Maria-Jose Sánchez, Roberta De Angelis, EUROCARE-6 Working Group | |
| 13. | [Comment] Finding the health-care expenditure that drives variation in cancer survival | Mark J Rutherford | |
| 14. | [Articles] Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials | Famke C Wakkerman, Jiqing Wu, Hein Putter, Ina M Jürgenliemk-Schulz, Jan J Jobsen, Ludy C H W Lutgens, Marie A D Haverkort, Marianne A de Jong, Jan Willem M Mens, Bastiaan G Wortman, Remi A Nout, Alicia Léon-Castillo, Melanie E Powell, Linda R Mileshkin, Dionyssios Katsaros, Joanne Alfieri, Alexandra Leary, Naveena Singh, Stephanie M de Boer, Hans W Nijman, Vincent T H B M Smit, Tjalling Bosse, Viktor H Koelzer, Carien L Creutzberg, Nanda Horeweg | |
| 15. | [Comment] Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer | Rosemary N Senguttuvan, Joshua G Cohen | |
| 16. | [News] IAEA facilitates sharing oncology expertise in Asia–Pacific region | Elizabeth Gourd | |
| 17. | [News] Initiatives to target cancer care and research in Africa | Paul Adepoju | |
更新于 49 分钟前
近期历史最近 100 条记录
| 2024-05-17 | [News] Medical debt of people with cancer in the USA | Talha Burki | |
| 2024-05-14 | [Articles] Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis | Huseyin Naci, Yichen Zhang, Steven Woloshin, Xiaodong Guan, Ziyue Xu, Anita K Wagner | |
| 2024-05-14 | [Articles] Effect of Project Orbis participation by the Swiss regulator on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis | Matea Zosso-Pavic, Qiyu Li, Eiman Atiek, Anita Wolfer, Ulrich-Peter Rohr | |
| 2024-05-14 | [Comment] Global cooperation and early access—clinical outcomes matter | Ariadna Tibau, Aaron S Kesselheim | |
| 2024-05-11 | [News] ESTRO 2024 | David Collingridge | |
| 2024-05-11 | [Articles] Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial | Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, Neal D Shore, Joost L Boormans, Ahmet Adil Esen, Thierry Lebret, Shuya Kandori, Dean F Bajorin, Laurence E M Krieger, Scot A Niglio, Edward M Uchio, Ho Kyung Seo, Ronald de Wit, Eric A Singer, Petros Griva | |
| 2024-05-11 | [News] Protests in South Africa over unused cancer-treatment fund | Paul Adepoju | |
| 2024-05-11 | [News] Cancer on the agenda during IAEA Director General's visit to Chile | Manjulika Das | |
| 2024-05-04 | [Articles] Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study | Bob T Li, Funda Meric-Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian Anderson, Giuseppe Curigliano, Maria de Miguel, Maitri Kalra, Do-Youn Oh, Joon Oh Park, Sophie Postel-Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, F | |
| 2024-05-03 | [News] Inadequate government funding for UK hospices affects palliative care | Elizabeth Gourd | |
| 2024-05-03 | [News] Biden administration delays long-awaited ban on menthol cigarettes | Bryant Furlow | |
| 2024-05-02 | [Articles] Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study | Milena Sant, Claudia Vener, Roberto Lillini, Silvia Rossi, Simone Bonfarnuzzo, Rafael Marcos-Gragera, Marc Maynadié, Kaire Innos, Keiu Paapsi, Otto Visser, Alice Bernasconi, Elena Demuru, Corrado Di Benedetto, Seyed Mohsen Mousavi, Marcel Blum, Philip Wen | |
| 2024-05-02 | [Comment] Finding the health-care expenditure that drives variation in cancer survival | Mark J Rutherford | |
| 2024-05-01 | [Articles] Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials | Famke C Wakkerman, Jiqing Wu, Hein Putter, Ina M Jürgenliemk-Schulz, Jan J Jobsen, Ludy C H W Lutgens, Marie A D Haverkort, Marianne A de Jong, Jan Willem M Mens, Bastiaan G Wortman, Remi A Nout, Alicia Léon-Castillo, Melanie E Powell, Linda R Mileshkin, | |
| 2024-05-01 | [Comment] Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer | Rosemary N Senguttuvan, Joshua G Cohen | |
| 2024-04-26 | [News] Initiatives to target cancer care and research in Africa | Paul Adepoju | |
| 2024-04-26 | [News] IAEA facilitates sharing oncology expertise in Asia–Pacific region | Elizabeth Gourd | |
| 2024-04-19 | [News] US EPA sets historic new restrictions on toxic PFAS in drinking water | Bryant Furlow | |
| 2024-04-19 | [News] Proposed bill to support assisted dying in France | Sharmila Devi | |
| 2024-04-13 | [News] Study bolsters concerns about US FDA accelerated drug approvals | Bryant Furlow | |
| 2024-04-13 | [News] Cancer Workforce Fund launched to address oncology workforce crisis | Emma Wilkinson | |
| 2024-04-13 | [Articles] Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study | Lance Turtle, Sarah Elliot, Thomas M Drake, Mathew Thorpe, Emma G Khoury, William Greenhalf, Hayley E Hardwick, Gary Leeming, Andy Law, Wilna Oosthuyzen, Riinu Pius, Catherine A Shaw, J Kenneth Baillie, Peter J M Openshaw, Annemarie B Docherty, Malcolm G | |
| 2024-04-13 | [Articles] [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial | Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M Joshua, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J Francis, Jeffrey C Goh, David A Pattison, Thean Hsiang Tan, Ian D Kirkwood, Craig Gedye, Natalie K Rutherford, Shah | |
| 2024-04-13 | [Comment] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer | Nadine Houédé, Kevin Hebert | |
| 2024-04-13 | [News] Nigeria revitalises national cancer response with new initiatives | Paul Adepoju | |
| 2024-04-12 | [News] Advisory Group recommendations on priorities for the IARC Monographs | Amy Berrington de González, Scott A Masten, Parveen Bhatti, Renée Turzanski Fortner, Susan Peters, Tiina Santonen, Marianna G Yakubovskaya, Robert Barouki, Silvia B M Barros, Dinesh Barupal, Laura E Beane Freeman, Gloria M Calaf, Joakim Dillner, Karima El | |
| 2024-04-10 | [Articles] Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial | Matthew T Campbell, Vania Balderrama-Brondani, Camilo Jimenez, Gina Tamsen, Leonardo P Marcal, Jeena Varghese, Amishi Y Shah, James P Long, Miao Zhang, Joshua Ochieng, Cara Haymaker, Mouhammed Amir Habra | |
| 2024-04-10 | [Comment] Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer? | Margaret E Wierman | |
| 2024-04-10 | [Articles] Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial | Ana Oaknin, Kathleen Moore, Tim Meyer, José López-Picazo González, Lot A Devriese, Asim Amin, Christopher D Lao, Valentina Boni, William H Sharfman, Jong Chul Park, Makoto Tahara, Suzanne L Topalian, Manuel Magallanes, Alejandro Molina Alavez, Tariq Aziz | |
| 2024-04-10 | [Articles] Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial | Camilo Jimenez, Mouhammed Amir Habra, Matthew T Campbell, Gina Tamsen, Damaris Cruz-Goldberg, James Long, Roland Bassett, Robert Dantzer, Vania Balderrama-Brondani, Jeena Varghese, Yang Lu | |
| 2024-04-06 | [Articles] MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study | Anna van der Voort, Fleur M Louis, Mette S van Ramshorst, Rob Kessels, Ingrid A Mandjes, Inge Kemper, Mariette J Agterof, Wim A van der Steeg, Joan B Heijns, Marlies L van Bekkum, Ester J Siemerink, Philomeen M Kuijer, Astrid Scholten, Jelle Wesseling, Ma | |
| 2024-04-06 | [News] Expansion of radiotherapy access in Ethiopia | Manjulika Das | |
| 2024-03-30 | [Articles] Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial | Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Danny Rischin, Gustavo Alves, Iane Pinto Figueiredo Lima, Brett G M Hughes, Yoann Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Jean-Pier | |
| 2024-03-29 | [News] Environmental pollution and cancer risk in La Oraya, Peru | Manjulika Das | |
| 2024-03-29 | [News] UK tobacco and vapes bill one step closer | Priya Venkatesan | |
| 2024-03-29 | [News] SSO 2024 | Allison Landman | |
| 2024-03-27 | [Articles] Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study | Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine, Zhihui Amy Liu, Logine Negm, Melissa Edwards, Vanessa Bianchi, Lucie Stengs, Jiil Chung, Abeer Al-Battashi, Agnes Reschke, Alex Lion, Alia Ahmad, Alvaro Lassaletta, Alyssa | |
匿名用户只展示最新 100 条榜单历史，更多历史数据请登录后查看，支持时光机按天筛选
Sponsors
